Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F10 | P00742 | 13/20 | 0.85 |
| ▸ | FPR2 | P25090 | 7/20 | 0.47 |
| ▸ | FPR1 | P21462 | 5/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6278106 | 0.97 | F10 (0.80) | F10FPR2FPR1 | |
| SCHEMBL6240640 | 0.92 | F10 (1.00) | F10FPR2FPR1 | |
| SCHEMBL6241120 | 0.89 | F10 (0.94) | F10FPR2FPR1 | |
| SCHEMBL6241778 | 0.89 | F10 (0.94) | F10FPR2FPR1 | |
| SCHEMBL6240978 | 0.89 | F10 (0.77) | F10FPR2FPR1 | |
| SCHEMBL6237385 | 0.88 | F10 (0.92) | F10FPR2FPR1 | |
| SCHEMBL6839419 | 0.88 | F10 (0.78) | F10FPR2FPR1 | |
| SCHEMBL6241699 | 0.87 | F10 (0.75) | F10FPR2FPR1 | |
| SCHEMBL6240505 | 0.87 | F10 (0.75) | F10FPR2FPR1 | |
| SCHEMBL6236705 | 0.87 | F10 (0.75) | F10FPR2FPR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040167131-A1 | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade | PFIZER INC. | 2004-08-26 | — | — | US | claimed |
| US-20040167131-A1 | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade | PFIZER INC. | 2004-08-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040167131-A1 | Inhibitors of factor Xa and other serine proteases involved in the coagulation cascade | TFPI, SERPINC1, F11 | F10 13/4885FPR2 1122/4885FPR1 582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.